Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Open in API
Filings indexed 170 across all filing types
Latest filing 2026-05-29 Share Issue/Capital Cha…
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
Ändring av antal aktier och röster i MedCap AB
Share Issue/Capital Change Classification · 85% confidence The document is a press release announcing the change in total number of shares and votes, and the corresponding increase in share capital due to the exercise of warrants. This constitutes a share issue/capital change announcement. Therefore, it fits the ‘Share Issue/Capital Change’ category (SHA).
2026-05-29 Swedish
Återköp av aktier i MedCap 15 maj 2026 - 20 maj 2026 – återköpsprogram avslutat
Transaction in Own Shares Classification · 95% confidence The document is a press release detailing MedCap AB’s completed share buyback program, including number of shares repurchased, transaction dates, and total values. This matches the definition of a Transaction in Own Shares (share repurchases).
2026-05-20 Swedish
Återköp av aktier i MedCap 7 maj 2026 – 13 maj 2026
Transaction in Own Shares Classification · 95% confidence The document is a press release detailing the company’s repurchase of its own shares (22,900 shares) under a board‐approved buyback program, including dates, volumes, prices, total transactions, and regulatory references (MAR, Safe Harbour regulation). This clearly matches the category for a transaction in own shares (share repurchase).
2026-05-13 Swedish
MedCap beslutar om aktieåterköpsprogram
Transaction in Own Shares Classification · 95% confidence The document is a press release dated May 6, 2026, announcing that MedCap's board has decided to initiate a share buyback program using authorization from the recent annual general meeting. The text details the terms and purpose of the share repurchase, including the maximum amount, price range, and timing. There are no financial statements or detailed financial results presented, nor is this a report or presentation. The content clearly relates to the company buying back its own shares. According to the filing definitions, announcements about share repurchase programs fall under 'Transaction in Own Shares' (POS). The document length is short (2572 characters), and it is an announcement, not a report or certification. Therefore, the correct classification is POS with high confidence.
2026-05-06 English
Stämmokommuniké årsstämma 4 maj 2026
AGM Information Classification · 95% confidence The document is a press release dated May 4, 2026, summarizing the decisions made at MedCap's Annual General Meeting (AGM) held on the same day. It includes details on board member elections, remuneration, auditor appointment, approval of financial statements, discharge of liability, approval of incentive programs, and authorizations for share buybacks and new share issues. The content is a summary of AGM resolutions rather than the full AGM materials or detailed financial reports. The document length is 4239 characters, which is relatively short and consistent with a meeting summary or announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or summaries of AGM decisions.
2026-05-04 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 92% confidence The document is titled “Delårsrapport Januari–Mars 2026” (Swedish for Interim Report January–March 2026) and covers detailed first‐quarter financial results, including full income statement, segment breakdowns, management commentary (VD-ord), cash flow, balance sheet metrics, and forward‐looking discussion. It is substantive (over 46,000 characters) and clearly constitutes the company’s actual interim/quarterly financial report rather than a brief announcement or presentation. Therefore, it matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-29 Swedish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.